COVID-19 Repurposed to Fight Cancer
This is a news story, published by ScienceBlog.com, that relates primarily to CCR2 news.
CCR2 news
For more CCR2 news, you can click here:
more CCR2 newsbiology news
For more biology news, you can click here:
more biology newsScienceBlog.com news
For more news from ScienceBlog.com, you can click here:
more news from ScienceBlog.comAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like biology news, you might also like this article about
immune cells. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest specific immune cell news, other immune cells news, biology news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
immune cellScienceBlog.com
•Could COVID-19 Offer Clues to New Cancer Treatments?
81% Informative
Scientists have uncovered how the body’s immune response to COVID-19 could be repurposed to fight cancer.
The immune cells in question, dubbed “inducible nonclassical monocytes (I-NCMs), have the ability to seek out and destroy cancer cells.
The research could pave the way for novel treatments for those suffering from cancers that have resisted all other forms of treatment.
2 . Which cancers were specifically studied in this research? The study focused on melanoma, lung, breast, and colon cancers. 3 . What makes I-NCMs unique compared to other immune cells? I-NCMs can infiltrate tumors, a capability most immune cells lack, due to the presence of the CCR2 receptor. 4. What is the next step for this research? The next step involves clinical trials to test the safety and effectiveness of this approach in cancer patients. Enjoy this story? Subscribe to our newsletter at scienceblog.substack.com.
VR Score
79
Informative language
76
Neutral language
49
Article tone
semi-formal
Language
English
Language complexity
50
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
11
Source diversity
3
Affiliate links
no affiliate links